Under the adept leadership of Dr. Chandrashekhar Mainde, ZHTL operates with a dedicated team spanning Research and Development (R&D), Quality Assurance (QA), Quality Control (QC), Regulatory Affairs (RA), and production. Dr. Mainde oversees and coordinates activities throughout the entire product development lifecycle, fostering collaboration among team members. From ideation to manufacturing, the team meticulously prepares regulatory dossiers and ensures compliance with industry standards, resulting in the successful registration of New Innovative Products (NIP). Dr. Mainde’s leadership cultivates a culture of excellence and innovation, propelling ZHTL towards achieving milestones in product development and registration, thus reinforcing its stature as a strong force in pharmaceutical innovation.

Dr. Mainde brings over 25 years of R&D and global business development experience. He is associated with leading pharmaceutical organisations and holds a proven track record, having successfully undergone approximately 75 audits by major regulatory authorities, including the USFDA, MHRA, ANVISA, TGA and EMA. He has led the filing of over 300 products with Turkey’s Ministry of Health (MOH), 10 AND submissions to the USA, and 50 EU CTD dossiers across various European countries.